La fenitoína es uno de los antiepilépticos más empleados por su gran utilidad para diferentes tipos de crisis y bajo costo. Sin embargo, su uso se ve limitado por los efectos adversos, en particular los que afectan al sistema nervioso central.
Carlos Alberto Calderon-Ospina +2 more
doaj +2 more sources
[Paediatric status epilepticus]. [PDF]
Soto-Insuga V +2 more
europepmc +1 more source
["Anti-NMDA-R encephalitis post-COVID-19: case report and proposed physiopathologic mechanism"]. [PDF]
Sanchez-Larsen A +3 more
europepmc +1 more source
[Systemic toxicity secondary to local anesthetic infiltration]. [PDF]
López-Ruiz R +5 more
europepmc +1 more source
PET coregistered with MRI imaging of anti-NMDAR encephalitis patient with SARS-CoV-2 infection. [PDF]
Mestre Fusco A +5 more
europepmc +1 more source
Clinical characteristics of patients with epilepsy attending primary health care. [PDF]
Arteaga-Rodríguez C +3 more
europepmc +1 more source
[The added value of Professional Pharmaceutical Assistance Services. A case of pharmaceutical care]. [PDF]
Abdala Kuri S +3 more
europepmc +1 more source
[Is there scientific evidence for the use of perampanel in neuropathic pain?] [PDF]
Alcántara-Montero A +1 more
europepmc +1 more source
Time until modification of antiparkinsonian therapy in a group of patients from Colombia. [PDF]
Valencia-Vásquez A +4 more
europepmc +1 more source
[Structural changes to the brain in drug-resistant juvenile myoclonic epilepsy]. [PDF]
Sánchez-Zapata P +2 more
europepmc +1 more source

